Arcadia Biosciences(RKDA)2025-03-20 20:06Revenue Growth - Total revenues for 2024 increased to 4,454,000 in 2023[4] - Product revenues rose to 4,437,000, indicating a 12.9% increase year-over-year[4] Net Loss and Improvement - The net loss for 2024 was 13,986,000 in 2023, reflecting a 49.7% improvement[6] - The company reported a comprehensive loss of 13,880,000 in 2023, showing a 48.6% improvement[4] Cash and Assets - Cash and cash equivalents decreased to 6,518,000, a decline of 34.9%[5] - Total assets decreased to 19,705,000 in 2023, a reduction of 31.4%[2] Liabilities and Expenses - Total liabilities increased slightly to 7,002,000 in 2023, an increase of 4.2%[2] - Operating expenses decreased to 10,555,000 in 2023, a reduction of 17.6%[4] Share Information - The weighted-average number of shares used in per share calculations increased to 1,363,303 in 2024 from 1,236,934 in 2023[4] Gains from Sales - The company recognized a gain of $4,000,000 from the sale of RS durum wheat trait in 2024[6]